Xcelerate, Inc. is a healthcare services and products company. The Company is engaged in three separate but related businesses within the medical, health and wellness sectors. The Company is focused on the development of medical technology and virtual health services to help patients in developing countries meet their medical needs by extending the reach of physicians through the technology; the formulation, packaging and marketing of consumer health and beauty, clinically tested skin and hair care products, and owning and licensing the rights to various forms of medical equipment.

Employees

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
17/09/26	USD 0.0160	+2.24%	110,000
15/09/26	USD 0.0157	+4.68%	46,550
14/09/26	USD 0.0150	+20.56%	152,500

Delayed Quote OTC Markets

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Delayed OTC Markets 01:10:42 17/09/26 am AEST			5-day change	1st Jan Change
0.0160 ^USD	+2.24%		+29.03%	+82.86%

14/05	Xcelerate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06/11	Xcelerate Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Market Cap	9.49M 8.23M 7.78M 7.06M 13.23M 911M 13.31M 92.82M 35.87M 462M 35.66M 34.87M 1.47B	P/E 2022	-16x	P/E 2023	-5.46x
Enterprise Value	10.7M 9.27M 8.76M 7.95M 14.91M 1.03B 15M 105M 40.42M 521M 40.18M 39.29M 1.66B	EV / Sales 2022	-	EV / Sales 2023	15,004,302x
Free-Float	58.58%	Yield 2022 *	-	Yield 2023	-

14/05	Xcelerate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06/11	Xcelerate Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
09/10/25	Noble Labs Holdings, LLC acquired an unknown majority stake in ESN Group, Inc from Xcelerate Inc..	CI
30/05/25	Xcelerate Inc. has withdrawn its IPO in the amount of $15 million.	CI
25/09/24	Xcelerate Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
22/08/24	Xcelerate, Inc. Announces Commencement of the Nationalization Process for Its PCT International Patent Applications	CI
31/07/24	Xcelerate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
30/04/24	Xcelerate Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
29/04/24	Xcelerate Inc. Auditor Raises 'Going Concern' Doubt	CI
13/11/23	Xcelerate Inc. has filed an IPO in the amount of $15 million.	CI
24/10/23	Xcelerate Inc. Announces Publication of Its Two Utility Patent Applications	CI
22/09/23	Xcelerate Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
08/08/23	Xcelerate Announces Marketing Agreement with ProductSector, LLC	CI

24/06	Xcelerate Announces Progress on Medical Deployment Program in Africa	AQ
04/05	Xcelerate Announces Agreements with Tanzanian Medical Professionals	AQ
09/10/25	Xcelerate Solutions Acquires clearAvenue	AQ
05/06/25	DHL launches Xcelerate: a premium fast-track airport-to-airport cargo service; Introducing a must-fly cargo product that prioritizes shipments and enhances customer experience with exceptional service.	AQ
02/11/24	Xcelerate, Inc. Announces Funding	AQ

Xcelerate Inc. Stock

Stocks

XCRT

US98401T1051

Healthcare Facilities & Services

Valuation: Xcelerate Inc.

Chart: Xcelerate Inc.

Latest news: Xcelerate Inc.

Press Releases: Xcelerate Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Xcelerate Inc.

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

1 day	+2.24%
1 week	+29.03%
Current month	+45.85%
1 month	+60.80%
3 months	+56.86%
6 months	+23.55%
Current year	+82.86%

1 week	0.01	0.02
1 month	0.01	0.02
Current year	0.01	0.02
1 year	0.01	0.02
3 years	0.01	0.06
5 years	0.01	0.14
10 years	0	0.17

Manager	Title	Age	Since
Michael O'Shea CEO	Chief Executive Officer	-	01/05/2020
Anja Glisovic CTO	Chief Tech/Sci/R&D Officer	-	04/09/2020

Director	Title	Age	Since
Michael O'Shea CHM	Chairman	-	-
Steve Gravely BRD	Director/Board Member	-	23/07/2020
Jason Householder BRD	Director/Board Member	-	04/08/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
XCELERATE INC.	+2.24%	+29.03%	0.00%	-70.91%	6.8M
CVS HEALTH CORPORATION	-1.35%	-1.98%	+27.23%	+32.23%	121B
HCA HEALTHCARE, INC.	+1.58%	+1.89%	+7.52%	+68.08%	91.76B
FRESENIUS SE & CO. KGAA	+1.62%	+1.58%	-3.14%	+52.16%	29.51B
QUEST DIAGNOSTICS INCORPORATED	-0.18%	+4.89%	+37.08%	+96.34%	27.27B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.13%	-0.65%	-4.12%	-2.45%	21.46B
TENET HEALTHCARE CORPORATION	+1.77%	-1.16%	+45.47%	+279.83%	21B
REDE D'OR SÃO LUIZ S.A.	+0.92%	+0.89%	-7.54%	+31.34%	15.65B
FRESENIUS MEDICAL CARE AG	+0.63%	+3.87%	-6.21%	-5.01%	12.17B
DAVITA INC.	+0.66%	+5.08%	+47.81%	+92.76%	12.17B
Average	+0.78%	+5.92%	+14.41%	+57.44%	35.19B
Weighted average by Cap.	+0.27%	+1.65%	+17.49%	+61.65%

	2022	2023
Net sales	-	1.12 0.97 0.92 0.83 1.56 107.64 1.57 10.97 4.24 54.6 4.22 4.12 174.03
Net income	-845K -732K -692K -628K -1.18M -81.03M -1.18M -8.26M -3.19M -41.1M -3.17M -3.1M -131M	-2.75M -2.38M -2.25M -2.05M -3.83M -264M -3.86M -26.9M -10.39M -134M -10.33M -10.1M -427M
Net Debt	113K 98.14K 92.76K 84.21K 158K 10.86M 159K 1.11M 428K 5.51M 425K 416K 17.56M	1.2M 1.04M 987K 896K 1.68M 116M 1.69M 11.78M 4.55M 58.62M 4.53M 4.43M 187M